News coverage about McKesson (NYSE:MCK) has trended somewhat positive this week, according to Accern. Accern scores the sentiment of media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. McKesson earned a daily sentiment score of 0.25 on Accern’s scale. Accern also gave news articles about the company an impact score of 47.5461892744235 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

These are some of the media stories that may have effected Accern Sentiment’s analysis:

McKesson (NYSE:MCK) traded up $0.03 during trading hours on Wednesday, reaching $160.67. The company’s stock had a trading volume of 1,270,723 shares, compared to its average volume of 1,439,100. The company has a quick ratio of 0.61, a current ratio of 1.05 and a debt-to-equity ratio of 0.66. McKesson has a twelve month low of $133.82 and a twelve month high of $169.29. The stock has a market capitalization of $33,330.00, a P/E ratio of 7.61, a P/E/G ratio of 1.61 and a beta of 1.23.

McKesson (NYSE:MCK) last released its earnings results on Thursday, October 26th. The company reported $3.28 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.78 by $0.50. The business had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.69 billion. McKesson had a return on equity of 24.87% and a net margin of 2.24%. The business’s revenue for the quarter was up 4.2% on a year-over-year basis. During the same period last year, the business posted $2.94 earnings per share. analysts forecast that McKesson will post 12.23 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, January 2nd. Stockholders of record on Friday, December 1st were given a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.85%. The ex-dividend date was Thursday, November 30th. McKesson’s dividend payout ratio (DPR) is presently 6.44%.

A number of brokerages recently commented on MCK. Zacks Investment Research raised McKesson from a “hold” rating to a “buy” rating and set a $177.00 price target for the company in a research report on Tuesday, December 26th. Morgan Stanley downgraded McKesson from an “overweight” rating to an “equal weight” rating and decreased their price target for the company from $184.00 to $172.00 in a research report on Thursday, September 14th. Evercore ISI began coverage on McKesson in a research report on Thursday, January 4th. They set an “outperform” rating and a $179.00 price target for the company. ValuEngine downgraded McKesson from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. Finally, Mizuho set a $168.00 price target on McKesson and gave the company a “hold” rating in a research report on Tuesday, October 24th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and eleven have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $174.64.

In other news, Chairman John H. Hammergren sold 65,000 shares of McKesson stock in a transaction on Thursday, December 14th. The stock was sold at an average price of $160.00, for a total value of $10,400,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.20% of the stock is currently owned by insiders.

COPYRIGHT VIOLATION NOTICE: “McKesson (MCK) Given Daily Media Sentiment Rating of 0.25” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright law. The original version of this story can be read at

About McKesson

McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare.

Insider Buying and Selling by Quarter for McKesson (NYSE:MCK)

Receive News & Stock Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related stocks with our FREE daily email newsletter.